Genetics of early-onset Alzheimer dementia.

Rosa V Rademakers, Marc Cruts, Christine Van Broeckhoven

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Alzheimer's dementia (AD) is the most common degenerative disorder of the central nervous system. Although the onset of dementia is above 65 years of age in the majority of the patients (late-onset AD, LOAD), a small subgroup of patients develops AD before 65 years of age (early-onset AD, EOAD). To date 3 genes responsible for EOAD have been identified: the amyloid precursor protein gene (APP), presenilin 1 (PSEN1) and presenilin 2 (PSEN2). PSEN1 is the most frequently mutated EOAD gene with a mutation frequency of 18 to 50% in autosomal dominant EOAD. In addition, the epsilon4 allele of the gene encoding apolipoprotein E (APOE) was identified as a risk factor for both LOAD and EOAD. Many studies reported other susceptibility genes, but the APOEepsilon4 alelle has been the only risk factor that was consistently replicated in all AD populations. Extensive cell biology research in the past ten years led to the hypothesis that the 4 EOAD genes lead to AD through a common biological pathway resulting in abnormal APP processing by subtle different mechanisms. Now, transgenic mice are produced to study the influence of EOAD mutations in vivo, eventually leading to the development of novel therapeutic strategies.

Original languageEnglish (US)
Pages (from-to)497-519
Number of pages23
JournalTheScientificWorldJournal [electronic resource]
Volume3
StatePublished - Jun 16 2003
Externally publishedYes

Fingerprint

Alzheimer Disease
Genes
gene
Presenilin-1
Amyloid beta-Protein Precursor
risk factor
Presenilin-2
mutation
Cytology
Gene encoding
Neurology
Apolipoproteins E
protein
Central Nervous System Diseases
Mutation Rate
nervous system
Genetics
Age of Onset
Transgenic Mice
Cell Biology

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Environmental Science(all)
  • Medicine(all)

Cite this

Genetics of early-onset Alzheimer dementia. / Rademakers, Rosa V; Cruts, Marc; Van Broeckhoven, Christine.

In: TheScientificWorldJournal [electronic resource], Vol. 3, 16.06.2003, p. 497-519.

Research output: Contribution to journalArticle

Rademakers, Rosa V ; Cruts, Marc ; Van Broeckhoven, Christine. / Genetics of early-onset Alzheimer dementia. In: TheScientificWorldJournal [electronic resource]. 2003 ; Vol. 3. pp. 497-519.
@article{3e4be5747ab441e29858ccd7ac46a7cd,
title = "Genetics of early-onset Alzheimer dementia.",
abstract = "Alzheimer's dementia (AD) is the most common degenerative disorder of the central nervous system. Although the onset of dementia is above 65 years of age in the majority of the patients (late-onset AD, LOAD), a small subgroup of patients develops AD before 65 years of age (early-onset AD, EOAD). To date 3 genes responsible for EOAD have been identified: the amyloid precursor protein gene (APP), presenilin 1 (PSEN1) and presenilin 2 (PSEN2). PSEN1 is the most frequently mutated EOAD gene with a mutation frequency of 18 to 50{\%} in autosomal dominant EOAD. In addition, the epsilon4 allele of the gene encoding apolipoprotein E (APOE) was identified as a risk factor for both LOAD and EOAD. Many studies reported other susceptibility genes, but the APOEepsilon4 alelle has been the only risk factor that was consistently replicated in all AD populations. Extensive cell biology research in the past ten years led to the hypothesis that the 4 EOAD genes lead to AD through a common biological pathway resulting in abnormal APP processing by subtle different mechanisms. Now, transgenic mice are produced to study the influence of EOAD mutations in vivo, eventually leading to the development of novel therapeutic strategies.",
author = "Rademakers, {Rosa V} and Marc Cruts and {Van Broeckhoven}, Christine",
year = "2003",
month = "6",
day = "16",
language = "English (US)",
volume = "3",
pages = "497--519",
journal = "The Scientific World Journal",
issn = "2356-6140",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Genetics of early-onset Alzheimer dementia.

AU - Rademakers, Rosa V

AU - Cruts, Marc

AU - Van Broeckhoven, Christine

PY - 2003/6/16

Y1 - 2003/6/16

N2 - Alzheimer's dementia (AD) is the most common degenerative disorder of the central nervous system. Although the onset of dementia is above 65 years of age in the majority of the patients (late-onset AD, LOAD), a small subgroup of patients develops AD before 65 years of age (early-onset AD, EOAD). To date 3 genes responsible for EOAD have been identified: the amyloid precursor protein gene (APP), presenilin 1 (PSEN1) and presenilin 2 (PSEN2). PSEN1 is the most frequently mutated EOAD gene with a mutation frequency of 18 to 50% in autosomal dominant EOAD. In addition, the epsilon4 allele of the gene encoding apolipoprotein E (APOE) was identified as a risk factor for both LOAD and EOAD. Many studies reported other susceptibility genes, but the APOEepsilon4 alelle has been the only risk factor that was consistently replicated in all AD populations. Extensive cell biology research in the past ten years led to the hypothesis that the 4 EOAD genes lead to AD through a common biological pathway resulting in abnormal APP processing by subtle different mechanisms. Now, transgenic mice are produced to study the influence of EOAD mutations in vivo, eventually leading to the development of novel therapeutic strategies.

AB - Alzheimer's dementia (AD) is the most common degenerative disorder of the central nervous system. Although the onset of dementia is above 65 years of age in the majority of the patients (late-onset AD, LOAD), a small subgroup of patients develops AD before 65 years of age (early-onset AD, EOAD). To date 3 genes responsible for EOAD have been identified: the amyloid precursor protein gene (APP), presenilin 1 (PSEN1) and presenilin 2 (PSEN2). PSEN1 is the most frequently mutated EOAD gene with a mutation frequency of 18 to 50% in autosomal dominant EOAD. In addition, the epsilon4 allele of the gene encoding apolipoprotein E (APOE) was identified as a risk factor for both LOAD and EOAD. Many studies reported other susceptibility genes, but the APOEepsilon4 alelle has been the only risk factor that was consistently replicated in all AD populations. Extensive cell biology research in the past ten years led to the hypothesis that the 4 EOAD genes lead to AD through a common biological pathway resulting in abnormal APP processing by subtle different mechanisms. Now, transgenic mice are produced to study the influence of EOAD mutations in vivo, eventually leading to the development of novel therapeutic strategies.

UR - http://www.scopus.com/inward/record.url?scp=1542754050&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1542754050&partnerID=8YFLogxK

M3 - Article

C2 - 12847300

AN - SCOPUS:1542754050

VL - 3

SP - 497

EP - 519

JO - The Scientific World Journal

JF - The Scientific World Journal

SN - 2356-6140

ER -